PCMR NEWS
04/21/2010
Grant Opportunity
The Children's Cardiomyopathy Foundation (CCF) is pleased to announce the availability of one-year research grants for studies focused on pediatric cardiomyopathy. The purpose of CCF’s Annual Research Grant Program is to advance knowledge of the basic mechanism of the disease and to develop more accurate diagnostic methods and improved therapies for children affected with cardiomyopathy. Please visit CCF’s website www.childrenscardiomyopathy.org (click on Research/Grants & Awards) for guidelines and to view past grant awards.
REQUEST FOR RESEARCH APPLICATIONS ON PEDIATRIC CARDIOMYOPATHY
Dilated, Hypertrophic, Restrictive, Left Ventricular Non-Compaction or
Arrhythmogenic Right Ventricular Cardiomyopathy
Opportunity:
The Children's Cardiomyopathy Foundation (CCF) is inviting investigator-initiated research proposals for innovative basic, clinical, population, or translational studies related to the cause, diagnosis, or treatment of primary cardiomyopathy in children under the age of 18 years. CCF's grant program is designed to provide seed funding to investigators for the testing of initial hypotheses and collecting of preliminary data to help secure long-term funding by the NIH and/or other major granting institutions.
Eligibility:
Principal investigator must hold an MD, PhD or equivalent degree and reside in the United States or Canada. The investigator must have a faculty appointment at an accredited U.S. or Canadian institution and have the proven ability to pursue independent research as evidenced in publications in peer-review journals.
Funding:
Funding is available in the range of US$25,000 to US$50,000 for one year of total direct costs. Following the completion of the proposed study, a second year of funding may be an option for relevant study extensions.
Application Process:
CCF grant guidelines and application forms are downloadable off the website at www.childrenscardiomyopathy.org/site/grants.php. The 2010 deadline for application submission is Friday, September 3, 2010 with final award decisions to be made by January 2011.
Selection Process:
Grant award decisions are made through a careful peer-review process led by CCF's Medical Advisors and reviewed by CCF’s Board of Directors. Scientific excellence and relevance to primary forms of pediatric cardiomyopathy are the main criteria for selecting research projects to support.
Contact:
Lisa Yue, President
Children’s Cardiomyopathy Foundation
Contact: 866-808-CURE ext. 901 or lyue@childrenscardiomyopathy.org
03/19/2009
Grant Opportunity
Dear Clinicians and Scientists,
The Children's Cardiomyopathy Foundation (CCF) is pleased to announce the availability of one-year research grants for studies focused on pediatric cardiomyopathy. The purpose of the award is to advance knowledge of the basic mechanism of the disease and to develop more accurate diagnostic methods and improved therapies for children affected with cardiomyopathy. Please visit CCF’s website www.childrenscardiomyopathy.org for more information and to view past grant awards.
REQUEST FOR RESEARCH APPLICATIONS ON PEDIATRIC CARDIOMYOPATHY
(Dilated, Hypertrophic, Restrictive or Left Ventricular Non-Compaction, Arrhythmogenic Right Ventricular Cardiomyopathy)
Opportunity:
The Children's Cardiomyopathy Foundation (CCF) is inviting investigator-initiated research proposals for innovative basic, clinical, population, or translational studies relevant to the cause, diagnosis, or treatment of cardiomyopathy in children under the age of 18 years. CCF's grant program is designed to provide seed funding to investigators for the testing of initial hypotheses and collecting of preliminary data to help secure long-term funding by the NIH and/or other major granting institutions.
Eligibility:
Principal investigator must hold an MD, PhD or equivalent degree and reside in the United States or Canada. The investigator must have a faculty appointment at an accredited U.S. or Canadian institution and have the proven ability to pursue independent research as evidenced in publications in peer-review journals.
Funding:
Funding is available in the range of US$25,000 to US$50,000 for one year of total direct costs. For grant renewals, CCF funding is limited to two years (consecutive or otherwise) of support.
How to Apply:
CCF grant guidelines and application forms are downloadable off the website at www.childrenscardiomyopathy.org/site/grants.php. The 2009 deadline for application submission is Friday, September 4, 2009 with final award decisions to be made by January 2010.
Selection Process:
Grant award decisions are made through a careful and detailed peer-review process led by CCF's Medical Advisors and reviewed by CCF’s Board of Directors. Scientific excellence and relevance to primary forms of pediatric cardiomyopathy are the main criteria for selecting research projects to support.
Contact:
Lisa Yue, President
Children’s Cardiomyopathy Foundation
PO Box 547
Tenafly, NJ 07670
Tel: 866-808-CURE (2873), ext 901
E-mail: lyue@childrenscardiomyopathy.org
09/26/2007
Presentations AvailableThe presentations from the Conference on Idiopathic and Primary Cardiomyopathy in Children: Research Directions and Strategies that took place in Bethesda, MD, in January 2007 are now available to view online. http://www.pediatrics.med.miami.edu/x431.xml
11/10/2004
The presentations and abstracts from the AHA conference are up on the Recent Publications page.
9/28/2004 - AHA Conference
There will be three PCMR presentations at the American Heart Association Conference in November.
- Impaired Functional Status in Children with Cardiomyopathy:
A Report from the Pediatric Cardiomyopathy Registry
Lynn Sleeper, ScD
November 7, 9:30AM - Outcome Predictors of Pediatric Hypertrophic Cardiomyopathy
Steven Lipshultz, MD
November 8, 10:30AM - Etiology-Specific Outcome in Pediatric Hypertrophic Cardiomyopathy
Steve Colan, MD
November 8, 2:00PM
Publications page updated.
